Background: Systemic Lupus Erythematosus Juvenile Rheumatoid Arthritis Rheumatoid Arthritis
Background: Systemic Lupus Erythematosus Juvenile Rheumatoid Arthritis Rheumatoid Arthritis
Background: Systemic Lupus Erythematosus Juvenile Rheumatoid Arthritis Rheumatoid Arthritis
Fever of unknown origin (FUO) was defined in 1961 by Petersdorf and Beeson as the
following: (1) a temperature greater than 38.3C (101F) on several occasions, (2) more
than 3 weeks' duration of illness, and (3) failure to reach a diagnosis despite 1 week of
inpatient investigation.[1, 2]
Diagnostic advances continuously modify the spectrum of FUO-causing diseases; for
example, serologic tests have reduced the importance of the human immunodeficiency
virus (HIV) and numerous rheumatic diseases (eg, systemic lupus
erythematosus [SLE], juvenile rheumatoid arthritis [JRA], rheumatoid arthritis[RA]) as
causes of FUO. (See Etiology and Serology.)
Modern imaging techniques (eg, ultrasonography, computed tomography [CT] scanning,
magnetic resonance imaging [MRI]) enable early detection of abscesses and solid tumors
that were once difficult to diagnose. (See Computed Tomography Scanning and Magnetic
Resonance Imaging.)
Patients with undiagnosed FUO (5-15% of cases) generally have a benign long-term
course, especially when the fever is not accompanied by substantial weight loss or other
signs of a serious underlying disease. These findings suggest that the underlying cause is
one of the more serious diseases that initially manifest as FUOs. Such underlying
diseases are usually diagnosed after an intensive and rational diagnostic evaluation. (See
Prognosis, History, and Diagnostic Considerations.)
Etiology
FUOs are caused by infections (30-40%), neoplasms (20-30%), collagen vascular
diseases (10-20%), and numerous miscellaneous diseases (15-20%). The literature also
reveals that, as previously mentioned, between 5 and 15% of FUO cases defy diagnosis,
despite exhaustive studies.
FUOs that persist for more than 1 year are less likely to be caused by an infection or
neoplasm and are much more likely to be the result of a granulomatous disease (the most
common cause in these cases).
The following conditions are sources of FUO:
Abscesses
Tuberculosis
Endocarditis
Hepatobiliary infections
Osteomyelitis
Rickettsia
Chlamydia
Spirochetal diseases
HIV
Herpes viruses
Fungal infections
Parasitic infections
Lymphomas
Leukemias
Solid tumors
Malignant histiocytosis
Sarcoidosis
Regional enteritis
Granulomatous hepatitis
Drug fever
Inherited diseases
Endocrine disorders
Kikuchi disease
Factitious fever
Abscesses
FUO should prompt consideration of abscesses, which are usually located intraabdominally, even in the absence of localizing symptoms. The most common abscess
locations include the subphrenic space, liver, right lower quadrant, retroperitoneal space,
and the female pelvis.
Tuberculosis
Tuberculosis (TB) is usually considered in the FUO differential diagnoses. (See
Differentials, below.)
Endocarditis
Spirochetal diseases
The most important spirochete is Borrelia recurrentis, which is transmitted by ticks and is
responsible for sporadic cases of relapsing fever. Rat-bite fever (Spirillum minor), Lyme
disease (Borrelia burgdorferi), and syphilis (Treponema pallidum) are other spirochetal
diseases that can cause FUO.
Parasitic infections
Consider toxoplasmosis in patients who are febrile with lymph node enlargement;
Malaria can also be a cause of fever. Other parasites that cause FUO, albeit in rare cases,
include Trypanosoma,Leishmania, and Amoeba species.
Leukemias
Acute leukemias are another important neoplastic group that can cause FUO.
Solid tumors
Among solid tumors, renal cell carcinoma is most commonly associated with FUO.
Other solid tumors, such as adenocarcinomas of the breast, liver, colon, or pancreas, as
well as liver metastases from any primary site, may also manifest as fever.
Malignant histiocytosis
This rare, rapidly progressive malignant disease is an occasional cause of FUO.
Regional enteritis
Drug fever
Although a wide variety of drugs can cause drug fever, the most common are beta-lactam
antibiotics, procainamide, isoniazid, alpha-methyldopa, quinidine, and
diphenylhydantoin.
Inherited diseases
In patients of Mediterranean descent with FUO, familial Mediterranean fever is most
often the cause.
Endocrine disorders
Hyperthyroidism and subacute thyroiditis are the 2 most common endocrinologic causes
of FUO. Adrenal insufficiency is a rare, potentially fatal, very treatable endocrinologic
source of FUO.
Kikuchi disease
Kikuchi disease is a self-limiting, necrotizing lymphadenitis. Its etiology is unknown.
Factitious fever
This is responsible for as many as 10% of FUO cases in some series and is most
commonly encountered among young adults with health care experience or knowledge.
Polyarteritis nodosa
This condition ranks a distant third, behind GCA and PMR, as one of the vasculitides that
causes FUO in patients older than age 50 years. PAN involves the medium- and smallsized muscular arteries. Incidence increases in patients with hepatitis B or C.
Uncommon causes of FUO include Wegener granulomatosis, Takayasu arteritis,
and cryoglobulinemia.
Epidemiology
More than 30% of FUO cases in persons older than 50 years are related to connectivetissue disorders and vasculitic diseases. GCA and PMR are the 2 principal connectivetissue etiologies, accounting for 50% of the cases.
In PAN, the male-to-female incidence ratio is 2:1.
Among patients with HIV infection, approximately 75% of cases of FUO are infectious
in nature, about 20-25% of cases are due to lymphomas, and 0-5% of cases are due to the
HIV itself.
Variations in FUO, as found in the literature, reflect the populations and periods studied.
In children, infections are the most common cause of FUO, whereas neoplasms and
connective-tissue disorders are more common in elderly persons.
The prognosis of FUO depends on the underlying cause and varies from patient to
patient. Complications of FUO, if they occur, are case dependent.
However, careful review of the literature shows that patients with FUO usually have a
benign long-term course, especially in the absence of substantial weight loss or other
signs of a serious underlying disease.
Patient Education